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Abstract
Background: Allergic rhinitis and asthma (ARA) are chronic inflammatory diseases of the airways that often coexist
in children. The only tool to assess the ARA control, the Control of Allergic Rhinitis and Asthma Test (CARAT) is to
be used by adults. We aimed to develop the Pediatric version of Control of Allergic Rhinitis and Asthma Test
(CARATkids) and to test its comprehensibility in children with 4 to 12 years of age.
Methods: The questionnaire development included a literature review of pediatric questionnaires on asthma
and/or rhinitis control and two consensus meetings of a multidisciplinary group. Cognitive testing was carried out
in a cross-sectional qualitative study using cognitive interviews.
Results: Four questionnaires to assess asthma and none to assess rhinitis control in children were identified. The
multidisciplinary group produced a questionnaire version for children with 17 questions with illustrations and
dichotomous (yes/no) response format. The version for caregivers had 4-points and dichotomous scales. Twenty-nine
children, 4 to 12 years old, and their caregivers were interviewed. Only children over 6 years old could adequately
answer the questionnaire. A few words/expressions were not fully understood by children of 6 to 8 years old. The
drawings illustrating the questions were considered helpful by children and caregivers. Caregivers considered the
questionnaire complete and clear and preferred dichotomous over the 4-points scales. The proportion of
agreement between children and their caregivers was 61%. The words/expressions that were difficult to understand
were amended.
Conclusion: CARATkids, the first questionnaire to assess a child’s asthma and rhinitis control was developed and its
content validity was assured. Cognitive testing showed that CARATKids is well-understood by children 6 to 12 years
old. The questionnaire’s measurement properties can now be assessed in a validation study.
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Background
Allergic rhinitis and asthma (ARA) are chronic inflamma-
tory diseases of the airways that often coexist. The concept
of “one airway one disease” was highlighted in the Allergic
Rhinitis and its Impact on Asthma (ARIA) guidelines and
the importance of an appropriate strategy combining safe
and effective management of both diseases, targeting opti-
mal control, in adults and children, was emphasized [1].
Questionnaires can be used as objective tools to evaluate
disease control. For adults, there are several question-
naires that were developed to assess asthma control [2-4].
In what concerns allergic rhinitis the concept of control is
still under definition [5]; nevertheless, some question-
naires have been proposed (Rhinitis Control Assessment
Test (RCAT) [6] and Allergic Rhinitis Control Test [7]).
For children, although the Practical Allergy (PRACTALL)
consensus report [8] emphasized the use of these tools to
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monitor asthma control, few questionnaires are available
[9-12]. And none to assess rhinitis control.
Based on ARIA recommendations, a single question-
naire should evaluate the control of asthma and allergic
rhinitis [1,13]. To account for this need, the Control of
Allergic Rhinitis and Asthma Test (CARAT) was devel-
oped and validated [14-16] and it has been proposed as
the first tool implementing ARIA guidelines in clinical
practice [13]. However, it was only validated for adult
patients [17] and such combined tool was still missing
for children. To address this problem we aimed to de-
velop the CARATkids - Control of Allergic Rhinitis and
Asthma Test for children – a questionnaire to concur-
rently assess control of allergic rhinitis and asthma in
children under 12 years old, with a medical diagnosis of
ARA. This article reports the process of development of
the CARATkids and the results of the cognitive testing
that lead to the preliminary version of the questionnaire.
Methods
Questionnaire development
The development of the test version of CARATkids was
performed in three steps (Figure 1), including a literature
review and two consensus meetings.
Literature review
A bibliographic search was conducted in MEDLINE
using as search terms: child/children, asthma, rhinitis,
questionnaire and/or control. Articles addressing ques-
tionnaire development and/or validation were selected
and retrieved. References of the selected articles were
searched for additional data sources. The data extracted
CONTENT VALIDITY
1st consensus meeting
(January 2010)
Literature review
(Scopus database) 4 pediatric questionnaires
– 4 about asthma control:
- The Asthma Quiz for Kidz
- Childhood Asthma Control Test
- Asthma Therapy Assessment Questionnaire (ATAQ) - Children
- Test for Respiratory and Asthma Control in Kids (TRACK)
– none about rhinitis control
– none about ARA control
CARAT17
(CARAT10)
26 portuguese experts in ARA
Allergologists
General Practitioners
Pediatricians
Pulmonologists
Group 2Group 1 Group 3
Independent proposal of a pool of questions
appropriate to evaluate control of ARA in children
Development of the first draft of the questionnaire
based on CARAT17
2nd consensus meeting
(January 2011) Presentation to the expert panel
Discussion of the first draft of the questionnaire
Changes to the first draft of the questionnaire
Approval of the testversion of the CARATkids
questionnaire (2 versions: children and caregivers)
Cognitive testing
Figure 1 Process of development of the CARATkids questionnaire. The CARATkids questionnaire was developed in sequential steps,
including literature review, 2 consensus meetings and a cognitive testing, to assure its content validity.
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included: age group and disease(s) of the target popula-
tion, item generation methods, intended respondent,
proportion of agreement between child and caregiver
when applicable, number of questions, time frame, an-
swering options (type of scales used), the presence of
drawings and items assessed.
First consensus meeting
A working group reviewed the existing data and pro-
posed a pool of questions on control of ARA in children.
This working group of 26 Portuguese experts in ARA,
including Pediatricians, General Practitioners, Pulmonol-
ogists and Allergologists, participated in a consensus
meeting, held in January 2010, where data on existing
pediatric questionnaires and the initial (CARAT17 [14])
and reduced versions of CARAT (CARAT10 [15,16]) for
adults were discussed. In this meeting, 3 groups inde-
pendently analyzed the existing questionnaires and pro-
posed questions to be included in CARATkids. After
pooling the proposed questions, it was unanimously de-
cided to use CARAT17 as the basis for the first draft
version of CARATkids as it covered all the questions
proposed (Figure 1).
The expert panel considered important that, at least
during the development of the questionnaire, both
child’s and their caregivers’ input were gathered using a
similar set of questions. This would imply two versions
of the questionnaire: one to be answered by the child
and another by the caregiver.
Second consensus meeting
In January 2011 the first draft of the questionnaire was
presented to the expert panel. The draft was discussed,
suggestions were presented, changes were made and a
test version of the questionnaire approved (Figure 1).
This development process was designed to assure the
content validity of the CARATkids questionnaire, accord-
ing to the recently published COSMIN (COnsensus-based
Standards for the selection of health Measurement Instru-
ments) checklist [18].
Cognitive testing
The cognitive testing was a cross-sectional, observa-
tional, qualitative study with face-to-face interview of a
convenience sample of 29 children and their parents/
caregivers. Children with 4 to 12 years old with medical
diagnosis of allergic rhinitis and asthma (Figure 2) were
enrolled between July and December 2011, during regu-
lar appointments at the Allergy outpatient clinic of the
Pediatric Hospital Dona Estefânia, in Lisbon, Portugal;
children and caregivers were eligible if they were native
Portuguese speakers. The interviews were performed in-
dependently by a psychologist and a physician. Children
and their caregivers were interviewed separately. The
participants were asked to read each question and re-
sponse aloud; when the children couldn’t read by him/her-
self, the questions were read aloud by the interviewers.
The answers were then challenged to make sure that the
questions had been correctly understood. The child’s ver-
sion was also discussed with the caregivers.
This study was conducted according to the principles
expressed in the Declaration of Helsinki. Verbal informed
consent was obtained from the caretakers of all children
participating in survey. These procedures were approved
by the institutional Ethical Review Board of the Hospital
CUF Descobertas, Lisbon, Portugal.
Results
Questionnaire development
Four questionnaires on asthma control were retrieved
(The Asthma Quiz for Kidz [9], Childhood Asthma Con-
trol Test (C-ACT), Asthma Therapy Assessment Ques-
tionnaire (ATAQ) for Children and Adolescents [11], Test
for Respiratory and Asthma Control in Kids (TRACK)
[12]). No questionnaires on control of rhinitis or concur-
rent assessment of ARA for children were found.
Two versions of the CARATkids questionnaire were
developed (child’s and caregiver’s) with slight differences
in wording and response options.
Child’s version
A 17-item questionnaire with dichotomous (Yes/No)
answer format accompanied by an illustrative colored
drawing was prepared. The dichotomous answer, similar
to “The Asthma Quiz for Kidz” and ATAQ for children,
was considered preferable for a child’s questionnaire as
it is easy to understand and answer.
In the child’s version, the expression of a specific
time-frame was included only in four questions. The ex-
pert panel considered the previous 2 weeks as the most
29 children and their parents/caregivers
– aged 4 to 12 years
– with medical diagnosis of ARA
Test version of CARATkids
Physician Psychologist
Children Parents/Caregivers
Caregiver’s versionChild’s version
Changes to the test versions
Figure 2 Cognitive testing of the CARATkids questionnaire.
Cognitive interviews were made independently by a psychologist
and a physician to each child and to one of his/her caregiver.
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adequate time-frame to be answered by children. In re-
lation to CARAT17 for adults, questions’ and headings’
vocabulary was adapted and/or simplified to be more
appropriate and easily understood by children (e.g.:
“school” instead of work).
Regarding the colored drawings for each question, it
was consensual to have only one version for both boys
and girls; the image of a boy was selected. The drawings
were discussed by the expert panel and improved until
approval.
Caregiver’s version
In the questionnaire for caregivers all questions had a
time-frame of 2 weeks. The caregiver version of the
questionnaire kept the format of CARAT17, namely a 4-
points Likert scale in questions 1 to 15 and a dichotom-
ous scale in questions 16 and 17. To make clear that this
questionnaire related to the child, all the questions in
the caregiver’s version included the expression “(…) your
child (…)”.
Cognitive testing
The characteristics of the children included in the cogni-
tive testing are summarized in Table 1.
Children with 4 to 5 years old were not able to read by
themselves and could not fully understand the question-
naire. Children with 6 years or older were able to under-
stand the questions; however, a few words, such as
“rhinitis” or “symptom” were not known by children
with 6 to 8 years. Moreover, the words/expressions “dys-
pnea” and “eye weep” were not understood by several
children, irrespective of age, and were removed. A few
words were replaced by synonyms that were more easily
understood by children and the sentence “respiratory/al-
lergic diseases” was abridged to “allergies”. All children
older than 9 years considered the questionnaire very
easy and clear. The children enjoyed the drawings and
found them clear and illustrative of the concepts. None
of the children or caregivers had questions or concerns
about the drawings.
Caregivers agreed that the questionnaire was complete
and no suggestion for additional questions were pro-
posed. They considered that the 2 weeks period time
was adequate. When considering the child’s version,
caregivers reported it to be clear and adequate; they ap-
preciated the dichotomic scale, considering it to be more
appropriate for their children, compared to the 4-point
Likert scale of the caregiver’s questionnaire. Most of the
caregivers were in favor of the inclusion of time frame in
the questions of the child’s version. Similarly, some chil-
dren opposed to the absence of a time frame in the
child’s version and older children specifically asked for
how long should they think about; this fact may have
caused some disagreement between the caregivers’ and
child’s answers. Nevertheless, four (out of 6) of the 6
years old children didn’t understand the time-frame of 2
weeks.
The proportion of agreement between children and
their caregivers was 61%; none of the child/caregiver
pairs agreed in all the answers. The symptoms of nasal
obstruction and throat itching were less reported by
caregivers than by their children.
The test version for children, revised after the cogni-
tive testing, is presented in Figure 3.
Discussion
The process of development of the CARATkids ques-
tionnaire included literature review, two consensus
meetings with a multidisciplinary expert panel and face-
to-face interviews with children and their caregivers for
cognitive testing. The cognitive testing showed that the
test version of CARATkids was easily understood and
answered by both caregivers and children with 6 years
or older. Younger children (4 to 5 years) were not able
to fully understand the questionnaire.
Most of the existing questionnaires evaluating asthma
control in children were developed based on clinical
guidelines (Table 2) and none assessed asthma and aller-
gic rhinitis concurrently. Within available question-
naires, CARAT17 was the only one assessing the control
of both asthma and allergic rhinitis and was based on a
comprehensive item generation process [14] making it
suitable to be the basis for development of CARATkids.
Moreover, the expert panel and the caregivers (in the
cognitive testing) had no suggestion for other questions
to be included or existing questions to exclude: this sup-
ports the relevance of the included items.
The importance of incorporating the child’s perspective
when evaluating asthma control has been highlighted in
several studies [9,10]; however, in younger children (espe-
cially when they are unable to read by themselves or don’t
know how to read properly), the parent/caregiver’s input
Table 1 Characteristics of the children included in the
cognitive testing (n = 29)
n (%)
Gender
Female 11 (38)
Age, years, median (P25-P75) 8(6–10)
4–5 3 (10)
6–9 15 (52)
10–12 11 (38)
Ability to read
Without help 18 (62)
With help 11 (38)
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may be essential [12]. In fact, we found that children
younger than 6 were unable to adequately understand the
questionnaire, suggesting that, in this age group, ARA
control may be best assessed by a tool to be answered by
the caregiver alone or with the child’s help. In older chil-
dren, the independent input of children and caregivers
ensures a broader perspective of diseases’ control and
overcomes the limitations associated with relying in one
isolated report, either from the child or the parent. Sup-
porting this decision, the cognitive testing of CARATkids
showed 39% disagreement between the symptoms re-
ported by the child and caregiver; this was already re-
ported by other studies [10,21]. The inclusion of nasal and
throat symptoms (e.g.: nasal obstruction and throat itch-
ing) may have heightened this disagreement. These symp-
toms are frequently long-lasting but mild enough not to
interfere majorly with the children’s daily activities; there-
fore, caregivers often don’t notice nasal or throat symp-
toms or regard them as “normal” or as part of a persistent
cold and not as a sign of an allergic disorder. Nevertheless,
the agreement between children and caregivers answers
should be reassessed in future studies with the final ver-
sion of the questionnaire.
The time frame used for assessment of control in
existing pediatric questionnaires is highly variable and
depends on the input (s) included (child vs. caregiver vs.
child and caregiver). However it seems consensual that
in child’s questions it is more appropriate and reliable to
evaluate short time periods. Childhood-ACT [10], for
example, uses “today” in questions to be answered for
children because in a round of interviews with children
aged 4–6 years, they presented difficulties recalling
Figure 3 Test version of CARATkids – child’s version.
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Table 2 Characteristics of CARATkids (test version) and comparison with other questionnaires analyzed during the consensus meetings
CARATkids (test
version)
ATAQ-Children C-ACT The asthma quiz for kidz TRACK CARAT17
Target population
Age group 4-12 years 5-17 years 4-11 years 1-17 years <5 years Adults
Disease (s) ARA Asthma Asthma Asthma Asthma ARA
Basis for
questionnaire
development
CARAT17 (Literature
review)
ATAQ for adults NAEPP guidelines [19]
GINA guidelines
(Literature review)
Clinical criteria of the Canadian Asthma
Consensus Statement [20]
Content generated from 2
focus groups‡ NAEPP
guidelines [19]
Literature review with item
generation
Questionnaire’s structure
Questions, n 17 20¥ 7 (4 + 3)* 6 5 17
Input (versions, n) Child and caregiver
(2)
Caregiver (1) Child and caregiver (1*) Child and caregiver (1)† Caregiver (1) NA
Agreement (child/
caregiver)
61% NA 80% 85% NA NA
Time frame Questions 1-14:
none Questions 15-
17: 2 W
Recent symptoms:
4 W Chronic
symptoms: 12 M
Child’s questions: present
Caregiver’s questions: 4 W
Questions 1-4: last week Questions 5-
6: preceding 30 D
Questions 1-3: 4 W Question
4: 3 M Question 5: 12 M
4 W
Scale (s) Dichotomous Dichotomous 4-point Likert Dichotomous 5-point Likert Questions 1–13, 15: 4-point
Likert Questions 14, 16, 17:
dichotomous
Drawings Yes (questions) No Yes (answers) Yes (questions) No NA
Items/symptoms - Nasal obstruction - Control: - Child: - Cough, wheeze or hard time
breathing
- Wheezing, coughing or
shortness of breath
- Nasal obstruction
- Sneezes – Wheeze with
exercise
– Asthma today - Sneezes
- Nasal itching
-Nasal itching -Wheeze not
exercising
–Asthma with exercise - Wake up at night - Nose dripping
- Interference with exercise
or usual activities
- Throat symptoms
- Nose dripping - Eye symptoms
- Throat symptoms – School absenteeism – Cough - Use of the blue puffer/pump
- Wake up at night - Shortness of breath
- Eye symptoms – Wake up during the
night
- use of rescue medication
- Shortness of
breath
– Daily activity loss - Cough, wheeze or hard time
breathing with exercise (less exercise
than previously)
- Wheezing
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Table 2 Characteristics of CARATkids (test version) and comparison with other questionnaires analyzed during the consensus meetings (Continued)
- Chest tightness with efforts
- Wheezing - Use of oral corticosteroids - Cough
- Tiredness in daily activities
– Parent assessment
of control
- Caregiver:
- Wake up during the night
- Chest tightness
with efforts
– Daytime symptoms
– Use of quick - Work/School absenteeism
- Cough
– Wheeze during the day
- Increase the use of
medication
- Tiredness in daily
- Go to a doctor
- Be hospitalized
Activities
- Wake up during
the night
Reliever – Wake up during the
night
- School absenteeism
– Dissatisfaction with
treatment
- Work/School
absenteeism
- Unscheduled medical appointment
- Increase the use
of medication
- Go to a doctor
- Be hospitalized
– Use of controller
medication
- Attitude/behavior
- Self-efficacy
- Patient-provider
communication
ATAQ – Asthma Therapy Assessment Questionnaire (ATAQ) for Children and Adolescents; CARAT17 – Control of Allergic Rhinitis and Asthma Test (17-item version); C-ACT – Childhood – Asthma Control Test; ACT – Asthma
Control Test; TRACK – Test for Respiratory and Asthma Control in Kids; CARATkids – Pediatric Control of Allergic Rhinitis and Asthma Test; ARA – Allergic Rhinitis and Asthma; NAEPP – National Asthma Education and
Prevention Program; GINA – Global Initiative for Asthma.
W - week; M – month; D – day; NA – Not applicable.
¥ 7 on asthma control; * includes different questions for child, 4 questions, and caregiver, 3 questions; † when the child is 8 years or younger the questionnaire is completed by the caregiver with the child’s input;
‡ including physicians and primary caregivers of children with recurring respiratory problems or asthma.
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beyond 1 day. In the existing questionnaires, none of the
questions to be answered by children evaluates more
than 4 weeks (Table 2). In the development of the CAR-
ATkids questionnaire it was decided to eliminate the
time frame from most of the questions based on the
knowledge that children, especially the younger/pre-
school, may be unable to remember or even understand
the concept of one week or one month. Only those
questions regarding the use of rescue medication, un-
scheduled medical visit and hospital admission (more
“relevant” events) reported specifically to the last 2
weeks. This option was very much discussed during con-
sensus meetings and by some children and caregivers in
the cognitive interviews and should be further studied.
The CARATkids questionnaire was designed with a
dichotomous-scale answer format, similar to The Asthma
Quiz for Kidz [9] and ATAQ for children [11]. This an-
swer format was considered adequate by children and
parents.
The inclusion of drawings illustrating each question
was also appreciated by the participants. This kind of
visual support was already used in The Asthma Quiz for
Kidz [9]; the C-ATC [10] also includes drawings, but
only to illustrate the answer options. It was consensually
decided to use the image of a boy and neither children
nor caregivers participating in the cognitive testing of
CARATkids reported questions related to the use of a
boy’s image; previous research [10] has shown that the
boy’s face is preferred by the majority of children (vs.
generic or girl’s face).
The cognitive test assured that the questionnaire was
adequately understood by both children and caregivers
and allowed to improve words and expressions that were
not sufficiently clear. This was a fundamental step in the
development of this questionnaire, providing in-depth
data, that was a major contribute to build a clear and ap-
pealing questionnaire. Moreover, it allowed the assess-
ment of its feasibility in the target age groups. The
comments of the caregivers supported the idea that
CARAT is an useful and adequate questionnaire to as-
sess asthma and rhinitis control. This process may seem
limited by the small number of participating children,
especially in the group with 4 to 5 years old. However,
as a qualitative methodology, cognitive interviews should
be stopped when no more new information is being ob-
tained. For children with 4 to 5 years old with a few in-
terviews was clear that the type of questionnaire we
were developing could not be applied. Therefore we stop
to interview children from that age group.
As far as we know, CARATkids is the first question-
naire aiming to assess control of asthma and allergic
rhinitis concurrently in children. It is being developed
following the COSMIN check-list [18] that evaluates the
methodological quality of studies on measurement
properties. Although this is not specific for childhood
questionnaires, we believe that the COSMIN initiative
[18] can help to improve the development and selection of
health measurement tools. Additional knowledge, specific-
ally regarding the development of pediatric questionnaires,
should be sought.
This article describes the aspects assuring the content
validity [18] of the CARATkids questionnaire. Additional
studies are needed to evaluate its measurement proper-
ties. A clinical prospective validation study is underway.
Conclusion
CARATkids, the first questionnaire to assess a child’s
asthma and rhinitis control was developed and its con-
tent validity was assured. Cognitive testing was import-
ant to guarantee that CARATKids is well-understood by
children 6 to 12 years old. The questionnaire’s measure-
ment properties can now be assessed in a prospective
validation study.
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